Pentoxifilina para el tratamiento de la úlcera venosa de pierna
Información
- DOI:
- https://doi.org/10.1002/14651858.CD001733.pub3Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 12 diciembre 2012see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Heridas
- Copyright:
-
- Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
AJ and BA identified studies from the initial search and selected studies for data extraction. AJ extracted the data from studies and this was independently reviewed for accuracy by JW. AJ synthesized the extracted data and drafted the report. VP conducted analyses testing for publication bias. VP, BA and JW reviewed the report. AJ coordinated the updated of the review and is the guarantor of the review.
Contributions of editorial base:
Nicky Cullum: edited the review, advised on methodology, interpretation and review content. Approved the final review prior to submission.
Sally Bell‐Syer: coordinated the editorial process. Advised on methodology, interpretation and content. Edited and copy edited the review and the updated review.
Ruth Foxlee: designed the search strategy, ran the searches and edited the search methods section for the update.
Sources of support
Internal sources
-
Clinical Trials Research Unit, University of Auckland, New Zealand.
-
Dept of General Practice & Primary Care, University of Auckland, New Zealand.
-
Auckland Healthcare Services, New Zealand.
External sources
-
NIHR/Department of Health (England), (Cochrane Wounds Group), UK.
Declarations of interest
Andrew B Jull, Varsha Parag and Jill Waters ‐ none known.
Bruce Arroll ‐ is on the advisory board for the educational seminars run by Pharmac, New Zealand's government funded drug purchasing agency. He is also on the primary care committee of the Future Forum and educational foundation funded by Astra Zeneca (UK). He has also accepted travel and conference funding from Sanofi Aventis.
Acknowledgements
We would like to thank:
-
Virginia Silvia of Sanofi‐Aventis for searching the manufacturer's databases and obtaining requested reports.
-
Andrea Nelson, Rick and Monika Wiechula, Sarah Hetrick (Co‐ordinator, Cochrane Subfertility and Dysmenorrhoea Group), Jorg Neumann, Martin O'Flaherty (Hospital Universitario Austral, Buenos Aires) and Felice Mussico (Azienda Ospedaliera San Camillo‐Forlanini, Rome) for assistance with translations.
-
Mary Paula Colgan, Reinhild Eberhardt, Andrea Nelson and Vincent Falanga for providing clarification regarding their trials.
-
David Margolis, C Vaughan Ruckley, June Jones, Linda O'Flynn, Anne‐Marie Bagnall, Peter Johnston, and Nicky Cullum who peer reviewed the review for methodological rigour, readability and clinical relevance.
-
Helen Handoll and Rajan Madhok (University of Hull, UK) for comments on the review post‐publication.
Version history
| Published | Title | Stage | Authors | Version |
| 2012 Dec 12 | Pentoxifylline for treating venous leg ulcers | Review | Andrew B Jull, Bruce Arroll, Varsha Parag, Jill Waters | |
| 2007 Jul 18 | Pentoxifylline for treating venous leg ulcers | Review | Andrew B Jull, Bruce Arroll, Varsha Parag, Jill Waters | |
| 2002 Jan 21 | Pentoxifylline for treating venous leg ulcers | Review | Andrew B Jull, Jill Waters, Bruce Arroll, Varsha Parag | |
